BFRI insider transaction filings

Biofrontera Inc. — 17 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-29. Screen BFRI transaction legs live →

FiledFormInsiderReported transactionsSource
2026-07-294Luebbert Hermann — CEO & Chairman, DirectorOption exercise (M): 62,500 · Option exercise (M): 62,500 (derivative) @ $0EDGAR
2026-07-294Leffler Eugene Frederick — Chief Financial OfficerOption exercise (M): 31,250 · Option exercise (M): 31,250 (derivative) @ $0EDGAR
2026-03-064Weber Kevin Daniel — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2026-03-064Luebbert Hermann — CEO & Chairman, DirectorOption exercise (M): 137,500 · Grant/award (A): 125,000 (derivative) @ $0 · Grant/award (A): 125,000 (derivative) @ $0 · Option exercise (M): 137,500 (derivative) @ $0EDGAR
2026-03-064Leffler Eugene Frederick — Chief Financial OfficerOption exercise (M): 87,500 · Grant/award (A): 62,500 (derivative) @ $0 · Grant/award (A): 62,500 (derivative) @ $0 · Option exercise (M): 87,500 (derivative) @ $0EDGAR
2026-03-064Lanckriet Heikki — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2026-03-064Hoffman Beth J. — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2026-03-064Jones George Patrick — Chief Commercial OfficerGrant/award (A): 50,000 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0EDGAR
2026-03-064BORER JOHN J III — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2025-09-184Biofrontera AG — Director, 10% ownerPurchase (P): 3,019 (derivative)EDGAR
2025-09-164Jones George Patrick — Chief Commercial OfficerGrant/award (A): 100,000 (derivative) @ $0EDGAR
2025-09-164Weber Kevin Daniel — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2025-09-164Luebbert Hermann — CEO & Chairman, DirectorOption exercise (M): 137,500 · Grant/award (A): 125,000 (derivative) @ $0 · Grant/award (A): 125,000 (derivative) @ $0 · Option exercise (M): 137,500 (derivative) @ $0EDGAR
2025-09-164Leffler Eugene Frederick — Chief Financial OfficerOption exercise (M): 87,500 · Grant/award (A): 62,500 (derivative) @ $0 · Grant/award (A): 62,500 (derivative) @ $0 · Option exercise (M): 87,500 (derivative) @ $0EDGAR
2025-09-164Lanckriet Heikki — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2025-09-164Hoffman Beth J. — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2025-09-164BORER JOHN J III — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR

Recent 8-K events — Biofrontera Inc.

FiledFormItems reportedSource
2026-08-138-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-178-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-148-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-198-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-098-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-02-268-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-02-098-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-138-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-078-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2025-11-138-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=BFRI returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →